125 Gastroenterologists to Know - R-S
Douglas K. Rex, MD (Indiana University Hospital, Indianapolis). Dr. Rex has been chairman of the board and president of the American College of Gastroenterologists. He is director of endoscopy at Indiana University Hospital and a professor of gastroenterology and medicine at Indiana University School of Medicine in Indianapolis. He co-authored the colorectal cancer screening recommendations of the ACG and those of the Gastroenterology Consortium. He is an associate editor of Journal Watch Gastroenterology and Reviews on Gastroenterological Disorders. Dr. Rex earned his MD at Indiana University School of Medicine and completed his residency and fellowship at Indiana University Medical Center. Research areas include colorectal disease and colorectal cancer screening and the technical performance of colonoscopy.
David T. Rubin, MD (University of Chicago). Dr. Rubin is program director for the gastroenterology fellowship at the University of Chicago, principal investigator for several research projects and clinical trials and is a member of the steering committee of the IBD Working Group. He serves as an invited reviewer for Gastroenterology, American Journal of Gastroenterology, Clinical Gastroenterology and Hepatology and Inflammatory Bowel Diseases.
Dr. Rubin serves on the ethics committee of the American Gastroenterological Association and on the professional issues committee at the American College of Gastroenterology. He earned his MD and completed a residency and a gastroenterology fellowship at the University of Chicago Pritzker School of Medicine. His research interests include colon cancer screening and prevention and inflammatory bowel disease.
Moshe Rubin, MD (New York Hospital, Queens, N.Y.). Dr. Rubin is director of gastroenterology at New York Hospital. He served as lead investigator in a research study that sought to determine whether vitamin D levels are associated with a person's ability to resolve a C-diff infection. His research shows real-time capsule endoscopy, when given in the ED, can rapidly identify patients with upper gastrointestinal bleeding who require urgent treatment. Dr. Rubin earned his MD from Yale University in New Haven, Conn., and completed his residency and fellowship at New York Presbyterian Hospital in New York.
Anil Rustgi, MD (University of Pennsylvania School of Medicine, Philadelphia). Dr. Rustgi is chief of the Division of Gastroenterology, director of the Center for Molecular Studies in Digestive and Liver Diseases and director of the Joint Center for Digestive, Liver and Pancreatic Medicine at the University of Pennsylvania School of Medicine. He is vice president of the American Gastroenterological Association. He earned his MD from Duke University in Durham, N.C., performed his residency at Beth Israel Hospital and Brockton VA in Boston, and completed his gastroenterology fellowship at Massachusetts General Hospital in Boston. His research interests include oncogenes, tumor suppressor genes, molecular genetics of GI cancers.
Michael A. Safdi, MD (Ohio Gastroenterology and Liver Institute, Cincinnati). Dr. Safdi helped formulate the first benchmarks for quality endoscopy when he served on a joint committee of the American College of Gastroenterology and American Society for Gastrointestinal Endoscopy. A member of Ohio Gastroenterology and Liver Institute, a group practice with 20 physicians, he built an arm of the practice that participated in more than 220 clinical research trials. He has been a surveyor for the Accreditation Association for Ambulatory Health Care since 1996 and is the ACG representative on the AAAHC's board.
Dr. Safdi earned his MD from University of Cincinnati Medical School and completed a residency and a fellowship at the University of California at San Diego. He received the Crohn's and Colitis Foundation of America Distinguished Leadership Award. He was an ACG board member and the college's representative to the Subspecialty Advisory Group for Socioeconomic Affairs for the American College of Physicians.
Robert A. Sable, MD (Riverdale Gastroenterology, Bronx, N.Y.). Dr. Sable has served as the medical staff president of Montefiore Medical Center and St. Barnabas Hospital in the Bronx and currently serves as co-medical director of the Advanced Endoscopy Center, also in the Bronx. He practices at six-physician Riverdale Gastroenterology, which he cofounded in 1981, and has an academic appointment at Albert Einstein College of Medicine in the Bronx. He earned his MD from Albert Einstein College of Medicine and completed a residency at Montefiore Medical Center and a gastroenterology fellowship at New York Medical College.
William J. Sandborn, MD (Mayo Clinic, Rochester, Minn.). Dr. Sandborn is vice chair of the Division of Gastroenterology and Hepatology at Mayo Clinic. He is involved in clinical trials and clinical pharmacology in inflammatory bowel disease and is the principal investigator on several clinical studies on the management of Crohn's disease and ulcerative colitis. Dr. Sandborn earned his MD and completed a residency at Loma Linda (Calif.) University and a fellowship at Mayo Clinic. He chairs the Immunology, Microbiology and Inflammatory Bowel Disease Section of the American Gastroenterological Association and the International Organization of Inflammatory Bowel Disease.
Robert S. Sandler, MD (University of North Carolina, Chapel Hill). The chief of the division of gastroenterology and hepatology at the University of North Carolina, Dr. Sandler is also longstanding director of the Center for Gastrointestinal Biology and Disease, an NIH-funded Digestive Disease Research Core Center based at UNC and North Carolina State University.
He has been an associate editor of Gastroenterology and served as president of the American Gastroenterological Association. Dr. Sandler earned his MD from Yale University School of Medicine in New Haven, Conn., and completed his residency at George Washington Hospital in Washington, D.C., and his fellowship at University of North Carolina.
Bruce E. Sands, MD (Massachusetts General Hospital, Boston). At Mass General, Dr. Sands is medical co-director of the Crohn's and Colitis Center and the Clinical Research and Gastrointestinal Unit. An associate professor of medicine at Harvard Medical School in Boston, he is vice chair of the Crohn's and Colitis Foundation of America's Clinical Alliance and is a member of the steering committee of the IBD Working Group. His research interests include treatment of Crohn's disease and ulcerative colitis.
Dr. Sands earned his MD at Boston University School of Medicine in Boston and completed a residency at the Hospital of the University of Pennsylvania in Philadelphia and clinical and research fellowships at Massachusetts General. He has also completed a master of science degree in epidemiology at the Harvard School of Public Health.
Harry Sarles Jr., MD (Digestive Health Associates of Texas, Garland). A member of Digestive Health Associates of Texas, Dr. Sarles is interested in colon cancer screening, pancreato-biliary problems of the GI tract, gastrointestinal bleeding problems and gastroesophageal reflux disease. He is secretary of the American College of Gastroenterologists and chairman of the legislative affairs committee for the Texas Society for Gastroenterology and Endoscopy. Dr. Sarles earned his MD and completed a residency at the University of Texas Medical Branch at Galveston and a fellowship at the VA Hospital in Phoenix through the University of Arizona.
Mark A. Schattner, MD (Memorial Sloan-Kettering Cancer Center, New York). Dr. Schattner is president of the New York Society for Gastrointestinal Endoscopy. Practicing at Memorial Sloan-Kettering, he has a special interest in therapeutic endoscopy and specialized nutrition support for cancer patients. Dr. Schattner earned his MD for the University of Pennsylvania School of Medicine and completed a residency at New York Hospital/Cornell Medical Center and a fellowship at Memorial Sloan-Kettering Cancer Center. He performs endoscopic procedures including colonoscopy, polypectomy, upper gastrointestinal endoscopy, endoscopic ultrasound, fine needle aspiration, capsule endoscopy and endoscopic placement of feeding tubes and stents.
Lawrence R. Schiller, MD (Digestive Health Associates of Texas, Dallas). Dr. Schiller is president-elect of the American College of Gastroenterology. A member of the board of Digestive Health Associates of Texas, he is also clinical professor at the University of Texas Southwestern in Dallas and program director of the gastroenterology fellowship at Baylor University Medical Center in Dallas. He is also chairman of the institutional review board for human subject protection at Baylor University Medical Center.
Dr. Schiller earned his MD from Thomas Jefferson University and completed a residency at Temple University Hospital, both in Philadelphia, and a fellowship at University of Texas Southwestern. His clinical interests include colon cancer screening gastroesophageal reflux disease, irritable bowel syndrome and Crohn's disease.
Colleen M. Schmitt, MD (Galen Medical Group, Chattanooga, Tenn.). A member of Galen Medical Group, Dr. Schmidt is a councilor for American Society of Gastrointestinal Endoscopy and was course director for the ASGE's Practical Solutions for Successful Practice Management in Aug. 2011. Dr. Schmitt earned her MD at the University of South Alabama in Mobile and completed a gastroenterology fellowship at Duke University in Durham, N.C.
Konrad S. Schulze, MD (University of Iowa, Iowa City). Born in Germany, Dr. Schulze is in the Department of Medicine at the University of Iowa. He has won the Award for Sustained Achievement in Digestive Sciences from the American Gastroenterological Association. Dr. Schulze earned an MD from the University of Munich and University of Heidelberg in Germany, completed his residency at Montreal General Hospital in Canada and his fellowship at the University of Iowa. His interests include the mechanics of gastric filling, phase separation and particle breakdown and correlations between visual parameters of contraction and their hydromechanical effects.
Srinivas Seela, MD (Digestive and Liver Center of Florida, Orlando). In addition to being part of three-physician Digestive and Liver Center of Florida, Dr. Seela is an assistant professor at the University of Central Florida School of Medicine and has privileges at Florida Hospital in Orlando. His interests include advanced and therapeutic endoscopic procedures, colorectal cancer screening, gastroesophageal reflux disease and metabolic and other liver disorders. Dr. Seela completed a gastroenterology fellowship at Yale University School of Medicine in New Haven, Conn.
Nicholas Shaheen, MD (University of North Carolina, Chapel Hill). Dr. Shaheen is president of the North Carolina Society of Gastroenterology and vice-chair of the Clinical Practice section of the American Gastroenterological Association. In addition to being director of the Center for Esophageal Diseases and Swallowing at the University of North Carolina, he serves on the editorial board of Gastroenterology, Evidence-Based Gastroenterology and Clinical and Translational Science, and is a reviewer for Gut, Gastroenterology and Hepatology and American Journal of Gastroenterology.
Dr. Shaheen earned his MD and completed his residency at the University of Chicago Pritzker School of Medicine and completed his fellowship at UNC, where he also earned a masters degree at the School of Public Health. He has won the Award for Outstanding Achievement in Basic or Clinical Digestive Sciences from the AGA Institute. His clinical interests are in Barrett's esophagus, reflux disease and esophageal cancer.
Helen M. Shields, MD (Beth Israel Deaconess Medical Center, Boston). Dr. Shields has served as chair of the Colorectal Cancer Screening Advisory Committee at Beth Israel Deaconess and is education and training councilor at the American Gastroenterological Association. She also holds an academic appointment at Harvard Medical School and is winner of the Distinguished Educator Award from AGA. Dr. Shields earned her MD from Tufts University School of Medicine in Boston and completed a residency at New York Hospital-Cornell Medical Center and a fellowship at University of Pennsylvania Health System in Philadelphia.
Corey A. Siegel, MD (Dartmouth-Hitchcock Medical Center, Lebanon, N.H.). The director of the Inflammatory Bowel Disease Center at Dartmouth-Hitchcock Medical Center, Dr. Siegel is also a section editor for Inflammatory Bowel Diseases and is a reviewer for Clinical Gastroenterology and Hepatology and Gastroenterology.
Dr. Siegel earned his MD from Tufts University in Boston, completed a residency and gastroenterology fellowship at Dartmouth-Hitchcock Medical Center in Lebanon, N.H., and completed an inflammatory bowel disease fellowship at Massachusetts General Hospital in Boston. Research interests include the risk-benefit trade-offs in inflammatory bowel disease and improving risk communication for patients. He is on the steering committee of the IBD Working Group.
Leonard B. Stein, MD (Long Island Center for Digestive Health, Garden City, N.Y.). Dr. Stein is medical director at the Long Island Center for Digestive Health, an endoscopy center performing 6,000 procedures a year, as well as a member of Gastroenterology Associates, a single-specialty group also in Garden City. He holds an academic appointment at State University of New York at Stony Brook. Dr. Stein earned his MD from Sackler School of Medicine in New York, completed a residency at Long Island Jewish Hospital and a gastroenterology fellowship at Temple University Hospital in Philadelphia.
Lewis R. Strong, MD (Skyline Endoscopy Center, Loveland, Colo.). Dr. Strong is the president of the Skyline Endoscopy Center, a Pinnacle III facility. Having served on numerous committees at McKee Medical Center in Loveland, part of Banner Health, he founded the local physician hospital organization and served as its president for four years. Dr. Strong earned his MD and completed his residency and fellowship at Case Western Reserve University in Cleveland.
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
- The Future of ACOs for Anesthesiologists
- Healthcare Exchange Traded Funds See Biggest Boom in Years
- FDA Issues Draft Guidance on Off-Label Use Information Dissemination
- Surgical Care Affiliates President & CEO Andrew Hayek Among 2014 Aspen Institute Henry Crown Fellows
- A Look at ASC Valuation Through the Eyes of M&D Companies